{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:18Z","timestamp":1791357498860,"version":"4.3.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"RJAH charitable funds"},{"name":"Professor Glenn Morris for providing access to laboratory facilities"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.eplepsyres.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T13:15:31Z","timestamp":1457702131000},"page":"97-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Anti-epileptic drugs and bone loss: Phenytoin reduces pro-collagen I and alters the electrophoretic mobility of osteonectin in cultured bone cells"],"prefix":"10.1016","volume":"122","author":[{"given":"Emma L.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Garton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi R.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.eplepsyres.2016.03.002_bib0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/neuonc\/noq044","article-title":"Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide","volume":"12","author":"Bobustuc","year":"2010","journal-title":"Neuro-oncol."},{"key":"10.1016\/j.eplepsyres.2016.03.002_bib0010","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1210\/en.2002-221044","article-title":"Osteonectin-null mutation compromises osteoblast forma-tion, maturation, and survival","volume":"144","author":"Delany","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.eplepsyres.2016.03.002_bib0015","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/pr1005263","article-title":"Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells","volume":"9","author":"Fuller","year":"2010","journal-title":"J. Proteome. Res."},{"key":"10.1016\/j.eplepsyres.2016.03.002_bib0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/toxsci\/59.1.118","article-title":"Effects of phenytoin on glutathionine status and oxidative stress biomarker gene mRNA levels in cultured precision human liver slices","volume":"59","author":"Gallagher","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.eplepsyres.2016.03.002_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(92)90426-8","article-title":"Carbamazepine-induced neurotoxicity and its prevention by NMDA in cultured cerebellar granule cells","volume":"135","author":"Gao","year":"1991","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.eplepsyres.2016.03.002_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/FTD.0b013e31827efe1d","article-title":"Factors influencing serum topiramate concentrations in routine therapeutic drug monitoring in Korean adult patients with epilepsy","volume":"35","author":"Huh","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.eplepsyres.2016.03.002_bib0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.eplepsyres.2013.06.011","article-title":"Valproate reduces collagen and osteonectin in cultured bone cells","volume":"106","author":"Humphrey","year":"2013","journal-title":"Epilepsy Res."},{"issue":"11","key":"10.1016\/j.eplepsyres.2016.03.002_bib0040","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/00003088-200645110-00002","article-title":"Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?","volume":"45","author":"Johannessen","year":"2006","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.eplepsyres.2016.03.002_bib0045","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/glycob\/cwh063","article-title":"Structural variability of BM-40\/SPARC\/osteonectin glycosylation: implications for collagen affinity","volume":"14","author":"Kaufmann","year":"2004","journal-title":"Glycobiology"},{"issue":"15","key":"10.1016\/j.eplepsyres.2016.03.002_bib0050","doi-asserted-by":"crossref","first-page":"9632","DOI":"10.1016\/S0021-9258(18)92867-X","article-title":"The collagen binding specificity of bone and platelet osteonectin is related to differences in glycosylation","volume":"266","author":"Kelm","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.eplepsyres.2016.03.002_bib0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjopharm.2010.02.003","article-title":"A review of the effect of anticonvulsant medications on bone mineral densityand fracture risk","volume":"8","author":"Lee","year":"2010","journal-title":"Am. J. Geriatr. Pharmacother."},{"issue":"4","key":"10.1016\/j.eplepsyres.2016.03.002_bib0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-Delta Ct method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.eplepsyres.2016.03.002_bib0065","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/14740331003636475","article-title":"Bone loss associated with use ofantiepileptic drugs","volume":"9","author":"Nakken","year":"2010","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.eplepsyres.2016.03.002_bib0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1535-7597.2003.03306.x","article-title":"The association between antiepileptic drugs and bone disease","volume":"3","author":"Pack","year":"2003","journal-title":"Epil. Curr."},{"key":"10.1016\/j.eplepsyres.2016.03.002_bib0075","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.eplepsyres.2016.03.002_bib0080","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jbmr.5650090507","article-title":"Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs","volume":"9","author":"V\u00e4lim\u00e4ki","year":"1994","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.eplepsyres.2016.03.002_bib0085","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-58-6-1003","article-title":"Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment","volume":"58","author":"Weinstein","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.eplepsyres.2016.03.002_bib0090","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ajhg.2015.04.021","article-title":"Recessive osteogenesis imperfecta caused by missense mutations in SPARC","volume":"96","author":"Mendoza-Londono","year":"2015","journal-title":"Am. J. Hum. Genet."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116300341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116300341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:35:51Z","timestamp":1760276151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121116300341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":18,"alternative-id":["S0920121116300341"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.03.002","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-epileptic drugs and bone loss: Phenytoin reduces pro-collagen I and alters the electrophoretic mobility of osteonectin in cultured bone cells","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}